| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967617 | Vaccine | 2012 | 8 Pages |
Abstract
⺠Systematic review of global hepatitis B prevalence and modeling of data. ⺠HBsAg-positive persons increased from 223 million in 1990 to 240 million in 2005. ⺠HBsAg prevalence varied geographically with highest endemicity in sub-Saharan Africa. ⺠HBsAg prevalence decreased overall but global differences exist. ⺠Demographic changes call for targeted hepatitis B prevention.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
J.J. Ott, G.A. Stevens, J. Groeger, S.T. Wiersma,